Shukra Pharmaceuticals Limited (BOM:524632)
India
· Delayed Price · Currency is INR 14.91
+0.29 (1.98%)
At close: Jun 12, 2025
Shukra Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, Shukra Pharmaceuticals had annual revenue of 367.94M INR, down -51.88%. Shukra Pharmaceuticals had revenue of 147.35M in the quarter ending March 31, 2025, with 29.96% growth.
Revenue
367.94M
Revenue Growth
-51.88%
P/S Ratio
17.40
Revenue / Employee
2.02M
Employees
182
Market Cap
6.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 367.94M | -396.72M | -51.88% |
| Mar 31, 2024 | 764.66M | 169.73M | 28.53% |
| Mar 31, 2023 | 594.93M | 390.07M | 190.41% |
| Mar 31, 2022 | 204.86M | 92.90M | 82.97% |
| Mar 31, 2021 | 111.96M | -6.50M | -5.49% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Life Insurance Corporation of India | 8,901.58B |
Shukra Pharmaceuticals News
- 5 months ago - Shukra Pharmaceuticals shares surge 90% in past one month; Check details - Business Upturn
- 5 months ago - Shukra Pharmaceuticals shares surge 166% in past one month; Check details - Business Upturn